Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

BOULDER, CO / ACCESSWIRE / August 3, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn^® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced the appointment of Dr. Hye Jin Chung MD, MMSc, Assistant Professor of Dermatology at Harvard Medical School in Boston and practicing dermatologist at Beth Israel Deaconess Medical Center, to the company's Scientific Advisory Board.

Sonoma's Scientific Advisory Board will be comprised of a small group of physicians with expertise in the areas of dermatology, skin care, wound care, eye, oral and nasal care, and animal health. The purpose of this Board is to allow the Sonoma's leadership team to gain insights that will inform the company's research and development activities, efforts to address areas of unmet need, and potential new areas of interest. Dr. Chung is an expert in her field of dermatology with extensive knowledge of skin conditions and treatments.

"We are thrilled to welcome Dr. Chung as the inaugural member of our Scientific Advisory Board," said Amy Trombly, CEO of Sonoma Pharmaceuticals. "Dr. Chung is an experienced practitioner and globally recognized researcher who has made significant contributions to the field of dermatology. Her knowledge and research on cosmetic dermatology and conditions such as acne and scars will be invaluable to our research and development efforts. We look forward to Dr. Chung's guidance and insights as we advance our research and development in the area of dermatology."

Dr. Chung graduated with her MD from Yonsei University College of Medicine, Seoul, Korea in 2001, where she completed her residency and fellowship training in Dermatology. She finished her post-doctoral fellowship and residency in dermatology at Thomas Jefferson University Hospital, Philadelphia, PA, in 2014. Dr. Chung joined the faculty of Dermatology, at Boston University School of Medicine, upon completion of her dermatopathology fellowship at Boston Medical Center in 2016 and maintained dual roles within the Department of Dermatology, evaluating patients in the Faculty Practice of Boston Medical Center and the Skin Pathology Laboratory at Boston University School of Medicine.